Research
Hormonal
HEC-CG115 reduced fasting blood glucose and glycated haemoglobin levels similar to those after semaglutide.
HEC-CG115 may provide effective glycaemic control for patients with type 2 diabetes.
StrongSupportsmedium confidence
HEC-CG115 (one dose every 3 days) reduced fasting blood glucose and glycated haemoglobin levels similar to those after semaglutide (once daily) at the same dose.
Why this rating
Based on the direct comparison of effects in animal models.
Source
Development of a novel <scp>Fc</scp> fusion protein dual glucagon‐like peptide‐1 and gastric inhibitory polypeptide receptor agonists
Peng Jiang et al. · Diabetes Obesity and Metabolism · 2023
otherCited 3×
Read the paper This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →